Hikma completed the acquisition of 17 brands in MENA region from Takeda Pharmaceuticals.

Hikma, a pharmaceutical company, completed the acquisition of 17 brands in MENA region from Takeda Pharmaceuticals, a pharmaceutical company. Financial terms were not disclosed. “We have been successfully commercialising this portfolio of products across the region for a number of years, supported by our highly-specialised sales and marketing team with strong local market expertise. By bringing these products in-house, we will not only ensure an uninterrupted supply of products to our customers but will also have better control of our supply chain, which will result in cost saving opportunities over the medium term. We are confident this acquisition will strengthen our Branded business and reinforce our commitment to provide high-quality medicines to patients in MENA,” Mazen Darwazah, Hikma Executive Vice Chairman and President of MENA.